Darae Ko1, Jonathan L Thigpen2, James A Otis3, Kristen Forster4, Lori Henault5, Emily Quinn6, Yorghos Tripodis6, Peter B Berger4, Nita Limdi7, Elaine M Hylek5. 1. Department of Medicine, Boston University School of Medicine, Boston, MA, United States. Electronic address: daraeko@bu.edu. 2. Department of Clinical and Administrative Sciences, Notre Dame of Maryland School of Pharmacy, Baltimore, MD, United States. 3. Department of Neurology, Boston University School of Medicine, Boston, MA, United States. 4. Department of Cardiology, Geisinger Health System, Danville, PA, United States. 5. Department of Medicine, Boston University School of Medicine, Boston, MA, United States. 6. Department of Biostatistics, Boston University School Public Health, Boston, MA, United States. 7. Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, United States.
Abstract
BACKGROUND: Statin pretreatment has been associated with reduced infarct volume in nonlacunar strokes. The effect of statins on functional outcomes of strokes related to atrial fibrillation (AF) is unknown. We aimed to define the influence of prestroke statin use on functional outcome in AF. METHODS: We assembled a cohort of consecutive ischemic stroke patients from 2006 to 2010. All patients underwent CT or MRI and were adjudicated by site investigators. AF was confirmed by electrocardiogram in 100% of patients. Site neurologists blinded to the study hypothesis affirmed the type of stroke and assessed the severity of disability at the time of hospital discharge. The frequency of death at 30-days was calculated. RESULTS: Ischemic stroke (n=1030) resulted in a severe neurological deficit or death (modified Rankin scale ≥4) at 30days in 711 patients (69%). Using multivariable logistic regression models adjusting for factors associated with statin treatment and factors associated with functional outcome, prestroke statin use was associated with a 32% reduction in frequency of severe stroke (odds ratio [OR], 0.68; 95% confidence interval [CI], 0.50-0.92; P=0.011). Other independent factors associated with severe stroke included older age, female sex, non-White race, diabetes mellitus, prior ischemic stroke, prior venous thromboembolism, and dementia. CONCLUSION: Ischemic strokes in AF are associated with high mortality and morbidity. Statin use at time of stroke onset among patients with AF was associated in this study with less severe stroke and warrant validation.
BACKGROUND: Statin pretreatment has been associated with reduced infarct volume in nonlacunar strokes. The effect of statins on functional outcomes of strokes related to atrial fibrillation (AF) is unknown. We aimed to define the influence of prestroke statin use on functional outcome in AF. METHODS: We assembled a cohort of consecutive ischemic strokepatients from 2006 to 2010. All patients underwent CT or MRI and were adjudicated by site investigators. AF was confirmed by electrocardiogram in 100% of patients. Site neurologists blinded to the study hypothesis affirmed the type of stroke and assessed the severity of disability at the time of hospital discharge. The frequency of death at 30-days was calculated. RESULTS:Ischemic stroke (n=1030) resulted in a severe neurological deficit or death (modified Rankin scale ≥4) at 30days in 711 patients (69%). Using multivariable logistic regression models adjusting for factors associated with statin treatment and factors associated with functional outcome, prestroke statin use was associated with a 32% reduction in frequency of severe stroke (odds ratio [OR], 0.68; 95% confidence interval [CI], 0.50-0.92; P=0.011). Other independent factors associated with severe stroke included older age, female sex, non-White race, diabetes mellitus, prior ischemic stroke, prior venous thromboembolism, and dementia. CONCLUSION:Ischemic strokes in AF are associated with high mortality and morbidity. Statin use at time of stroke onset among patients with AF was associated in this study with less severe stroke and warrant validation.
Authors: Apurva O Badheka; Ankit Rathod; Mohammad A Kizilbash; Neha Garg; Tamam Mohamad; Luis Afonso; Sony Jacob Journal: Am J Cardiol Date: 2010-04-27 Impact factor: 2.778
Authors: Anetta Undas; Magdalena Celinska-Löwenhoff; Kathleen E Brummel-Ziedins; Jan Brozek; Andrew Szczeklik; Kenneth G Mann Journal: Arterioscler Thromb Vasc Biol Date: 2005-07 Impact factor: 8.311
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2014-03-28 Impact factor: 24.094
Authors: Steven J Shook; Rishi Gupta; Nirav A Vora; Andrew L Tievsky; Irene Katzan; Derk W Krieger Journal: J Neuroimaging Date: 2006-10 Impact factor: 2.486
Authors: Ye Sel Kim; Moo-Seok Park; Jun-Hwa Lee; Jong-Won Chung; Mi Ji Lee; Chi Kyung Kim; Jin-Man Jung; Kyungmi Oh; Oh Young Bang; Geong-Moon Kim; Ji-Mi Choi; Juneyoung Lee; Chin Sang Chung; Kwang Ho Lee; Woo-Keun Seo Journal: Front Neurol Date: 2018-04-24 Impact factor: 4.003